Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.
Our website will be undergoing planned maintenance starting at 5:00 PM EST on Dec. 11 and will be back in the morning of Dec. 12. During this time some features will be unavailable, like login and signup.

ISO / Technical Committee 212

CLSI manages the committee’s program of work through the ISO consensus process according to the ISO Directives, and provides administrative support.

The scope of ISO/TC 212 is: “Standardization and guidance in the field of laboratory medicine and in vitro diagnostic test systems. This includes, for example, quality management, pre- and post-analytical procedures, analytical performance, laboratory safety, reference systems and quality assurance.”

The following is excluded:

  • Generic quality management standards addressed by ISO/TC 176
  • Quality management standards for medical devices addressed by ISO/TC 210
  • Reference material guidelines addressed by the ISO Committee on Reference Materials (REMCO)
  • Conformity assessment guidelines addressed by the ISO Committee on Conformity Assessment (CASCO)

Dr. David Armbruster is the ISO/TC 212 chairman, and ISO/TC 212 is divided into five working groups, as follows:

  • Working Group 1, Quality and competence in the medical laboratory (convenor – Ms. Sheila Woodcock, Canada)
  • Working Group 2, Reference systems (convenor – Dr. Neil Greenberg, USA)
  • Working Group 3, In vitro diagnostic products (convenor – Dr. Claude Giroud, France)
  • Working Group 4, Microbiology and molecular diagnostics (convenor – Dr. Uwe Oelmueller, Germany)
  • Working Group 5, Laboratory biorisk management (convenor – Dr. Gary Burns, UK)